Publications and communications of Anne-Catherine Lange

Messina, A., Schyns, M., Dozo, B.-O., Denoël, V., Van Hulle, R., Etienne, A.-M., Delroisse, S., Bruyère, O., D'Orio, V., Fontaine, S., Guillaume, M., Lange, A.-C., Louppe, G., Michel, F., Nyssen, A.-S., Bureau, F., Haubruge, E., Donneau, A.-F., Gillet, L., & Saegerman, C. (2023). Developing a video game as an awareness and research tool based on SARS-CoV-2 epidemiological dynamics and motivational perspectives. Transboundary and Emerging Diseases. doi:10.1155/2023/8205408

Parisi, G., Renault, V., Humblet, M.-F., Ochelen, N., Diep, A. N., Guillaume, M., Donneau, A.-F., Bureau, F., Gillet, L., Lange, A.-C., Michel, F., Fontaine, S., & Saegerman, C. (13 September 2022). Compliance with Barrier Gestures during COVID-19 Pandemic as a Function of the Context: A Longitudinal Observational Survey at the University of Liège. International Journal of Environmental Research and Public Health, 19 (18). doi:10.3390/ijerph191811523

Denoël, V.* , Bruyère, O.* , Louppe, G., Bureau, F., D'ORIO, V., Fontaine, S., Gillet, L., Guillaume, M., Haubruge, E., Lange, A.-C., Michel, F., Hulle, R. V., Arnst, M., Donneau, A.-F.* , & Saegerman, C.*. (04 March 2022). Decision-based interactive model to determine re-opening conditions of a large university campus in Belgium during the first COVID-19 wave. Archives of Public Health, 80 (1). doi:10.1186/s13690-022-00801-w
* These authors have contributed equally to this work.

Tessier, A., Dupuis, M., Baylé, F. J., Herse, C., Lange, A.-C., Vrijens, B., Schweitzer, P., Swendsen, J., & Misdrahi, D. (March 2020). Brief interventions for improving adherence in schizophrenia: A pilot study using electronic medication event monitoring. Psychiatry Research, 285. doi:10.1016/j.psychres.2020.112780

Wessels, A. M., Jin, Y., Pollock, B. G., Frank, E., Lange, A.-C., Vrijens, B., Fagiolini, A., Kupfer, D. J., Rucci, P., Kepple, G., Anderton, J., Buttenfield, J., & Bies, R. R. (November 2012). Adherence to escitalopram treatment in depression: a study of electronically compiled dosing histories in the 'Depression: the search for phenotypes' study. International Clinical Psychopharmacology, 27 (6), 291-7. doi:10.1097/YIC.0b013e3283597678

Cooper, V., Horne, R., Gellaitry, G., Vrijens, B., Lange, A.-C., Fisher, M., & White, D. (March 2010). The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study. Journal of acquired immune deficiency syndromes (1999), 53 (3), 369-77. doi:10.1097/QAI.0b013e3181ccb762